Merck (MRK) EBT Margin (2009 - 2026)

Merck has disclosed EBT Margin across 18 years of filings, most recently posting 21.49% for Q1 2026.

• In Q1 2026, EBT Margin fell 5950.0% year-over-year to 21.49%; the TTM figure through Mar 2026 stood at 17.74% (down 1382.0% YoY), while the FY2025 annual figure was 32.41%, up 134.0% from the prior year.
• EBT Margin eased to 21.49% in Q1 2026, from 20.85% in the prior quarter.
• Over the last five years, EBT Margin for MRK reached as high as 39.04% in Q3 2025 and fell as low as 35.25% in Q2 2023.
• The 5-year median for EBT Margin is 26.69% (2024), against an average of 20.84%.
• Annual changes were most pronounced in 2023 — EBT Margin sank 6600 bps — and 2024, when it jumped 7253 bps.
• A 5-year view of EBT Margin shows it stood at 25.4% in 2022, then sank by 155 bps to 13.98% in 2023, then jumped by 291 bps to 26.69% in 2024, then decreased by 22 bps to 20.85% in 2025, then tumbled by 203 bps to 21.49% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 21.49%, 20.85%, and 39.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.